GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 98 filers reported holding GOSSAMER BIO INC in Q1 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -91.7% | 530 | -94.5% | 0.00% | – |
| Q1 2023 | $12 | -87.8% | 9,630 | -78.6% | 0.00% | – |
| Q4 2022 | $98 | -100.0% | 45,030 | -23.4% | 0.00% | -100.0% |
| Q3 2022 | $704,000 | +170.8% | 58,763 | +89.4% | 0.00% | – |
| Q2 2022 | $260,000 | -32.6% | 31,019 | -30.2% | 0.00% | – |
| Q1 2022 | $386,000 | -23.3% | 44,468 | +0.1% | 0.00% | -100.0% |
| Q4 2021 | $503,000 | -10.2% | 44,431 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $560,000 | +47.4% | 44,545 | -4.8% | 0.00% | – |
| Q2 2021 | $380,000 | -11.2% | 46,774 | +1.0% | 0.00% | – |
| Q1 2021 | $428,000 | -4.5% | 46,300 | 0.0% | 0.00% | – |
| Q4 2020 | $448,000 | -22.1% | 46,300 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $575,000 | -4.5% | 46,300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $602,000 | +54.0% | 46,300 | +20.3% | 0.00% | 0.0% |
| Q1 2020 | $391,000 | -35.0% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $602,000 | -7.4% | 38,500 | -0.5% | 0.00% | 0.0% |
| Q3 2019 | $650,000 | +2.7% | 38,700 | +35.5% | 0.00% | 0.0% |
| Q2 2019 | $633,000 | +261.7% | 28,558 | +254.4% | 0.00% | – |
| Q1 2019 | $175,000 | – | 8,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
| Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
| Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
| NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
| Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
| HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
| Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
| Birchview Capital, LP | 99,088 | $118,906 | 0.09% |